Skip to content

Drug interactions

Efavirenz + Glimepiride-pioglitazone

Severity: Minor

Efavirenz and Glimepiride-pioglitazone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz induces CYP3A4 and may lower pioglitazone concentrations, possibly reducing its glucose-lowering effect. The effect is likely small because CYP2C8 is the main pathway for pioglitazone.

What this interaction means in plain words

Efavirenz and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Efavirenz belongs to Anti Virals; Glimepiride-pioglitazone belongs to Endocrine.

Evidence level: Low

Why it happens

Induction of CYP3A4 (and possibly CYP2B6/2C enzymes) by efavirenz increasing pioglitazone metabolism.

What to do

Monitor glycemic control (blood glucose and HbA1c) after starting or stopping efavirenz and adjust the pioglitazone dose if control changes.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Glimepiride-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Glimepiride-pioglitazone?

MediHelp rates the interaction as minor. Efavirenz and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Efavirenz induces CYP3A4 and may lower pioglitazone concentrations, possibly reducing its glucose-lowering effect. The effect is likely small because CYP2C8 is the main pathway for pioglitazone.

How serious is the interaction between Efavirenz and Glimepiride-pioglitazone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glycemic control (blood glucose and HbA1c) after starting or stopping efavirenz and adjust the pioglitazone dose if control changes.

What other medicines interact with Glimepiride-pioglitazone?

MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in